Daniel Selchen

3.8k total citations
39 papers, 1.1k citations indexed

About

Daniel Selchen is a scholar working on Pathology and Forensic Medicine, Neurology and Epidemiology. According to data from OpenAlex, Daniel Selchen has authored 39 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pathology and Forensic Medicine, 13 papers in Neurology and 6 papers in Epidemiology. Recurrent topics in Daniel Selchen's work include Multiple Sclerosis Research Studies (19 papers), Peripheral Neuropathies and Disorders (9 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Daniel Selchen is often cited by papers focused on Multiple Sclerosis Research Studies (19 papers), Peripheral Neuropathies and Disorders (9 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Daniel Selchen collaborates with scholars based in Canada, United States and Spain. Daniel Selchen's co-authors include Gustavo Saposnik, Mark S. Freedman, Roseanna Presutti, Qiyun Shi, Alexandre Prat, Yves Lapierre, Douglas L. Arnold, Brenda Banwell, Michael Yeung and François Grand’Maison and has published in prestigious journals such as Neurology, Stroke and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Daniel Selchen

38 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Selchen Canada 19 533 382 205 142 138 39 1.1k
Christian A. Bowers United States 25 323 0.6× 752 2.0× 415 2.0× 54 0.4× 68 0.5× 204 2.2k
Thomas Schenk Germany 23 145 0.3× 238 0.6× 142 0.7× 147 1.0× 119 0.9× 59 1.5k
Virender Bhan Canada 19 1.1k 2.2× 374 1.0× 159 0.8× 142 1.0× 259 1.9× 40 1.6k
Shearwood McClelland United States 27 392 0.7× 585 1.5× 277 1.4× 269 1.9× 31 0.2× 180 2.4k
J. Gareth Noble United Kingdom 22 359 0.7× 121 0.3× 147 0.7× 66 0.5× 173 1.3× 46 1.5k
Kathleen Costello United States 18 1.1k 2.1× 421 1.1× 110 0.5× 165 1.2× 127 0.9× 45 1.6k
Nhial T. Tutlam United States 14 541 1.0× 214 0.6× 63 0.3× 52 0.4× 150 1.1× 34 1.1k
Bruno P. Soares United States 21 229 0.4× 569 1.5× 459 2.2× 39 0.3× 94 0.7× 88 1.7k
Joel C. Morgenlander United States 20 66 0.1× 423 1.1× 114 0.6× 40 0.3× 49 0.4× 61 994
John Y. Choi United States 17 94 0.2× 276 0.7× 446 2.2× 49 0.3× 77 0.6× 50 1.5k

Countries citing papers authored by Daniel Selchen

Since Specialization
Citations

This map shows the geographic impact of Daniel Selchen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Selchen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Selchen more than expected).

Fields of papers citing papers by Daniel Selchen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Selchen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Selchen. The network helps show where Daniel Selchen may publish in the future.

Co-authorship network of co-authors of Daniel Selchen

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Selchen. A scholar is included among the top collaborators of Daniel Selchen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Selchen. Daniel Selchen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jairath, Vipul, Waqqas Afif, Brian Bressler, et al.. (2024). Practical guidance for managing patients with moderate-to-severe ulcerative colitis using small molecule therapies. Journal of the Canadian Association of Gastroenterology. 7(4). 282–289. 2 indexed citations
2.
Suthiphosuwan, Suradech, Jonathan A. Micieli, Reza Vosoughi, et al.. (2024). Low-Field (64 mT) Portable MRI for Rapid Point-of-Care Diagnosis of Dissemination in Space in Patients Presenting with Optic Neuritis. American Journal of Neuroradiology. 45(11). 1819–1825. 5 indexed citations
3.
Schneider, Raphaël, et al.. (2023). Acute central nervous system inflammation following COVID-19 vaccination: An observational cohort study. Multiple Sclerosis Journal. 29(4-5). 595–605. 4 indexed citations
4.
Schneider, Raphaël, et al.. (2022). Acute Central Nervous System Demyelination Following COVID-19 Vaccination. Neurology. 99(23_Supplement_2). 1 indexed citations
5.
Rieckmann, Peter, Diego Centonze, Gavin Giovannoni, et al.. (2021). Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice. Therapeutic Advances in Neurological Disorders. 14. 4203339386–4203339386. 11 indexed citations
6.
Oh, Jiwon, Suradech Suthiphosuwan, Pascal Sati, et al.. (2021). Cognitive impairment, the central vein sign, and paramagnetic rim lesions in RIS. Multiple Sclerosis Journal. 27(14). 2199–2208. 39 indexed citations
7.
Jones, Ashley, Marika Hohol, Kristen M. Krysko, et al.. (2021). Clinical Characteristics and Outcomes of Multiple Sclerosis Patients with COVID-19 in Toronto, Canada (1556). Neurology. 96(15_supplement). 1 indexed citations
8.
Genge, Angela, et al.. (2021). Complement Inhibition in Myasthenia Gravis and Neuromyelitis Optica Spectrum Disorder. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 50(2). 165–173. 7 indexed citations
9.
Bain, Julie, et al.. (2020). Early Real-World Safety, Tolerability, and Efficacy of Cladribine Tablets: A Single Center Experience (400). Neurology. 94(15_supplement). 2 indexed citations
10.
Rotstein, Dalia, Aditya Bharatha, & Daniel Selchen. (2018). Severe aseptic temporal lobe encephalitis on fingolimod. Multiple Sclerosis and Related Disorders. 23. 4–6. 2 indexed citations
11.
Saposnik, Gustavo, Xavier Montalbán, Daniel Selchen, et al.. (2018). Therapeutic Inertia in Multiple Sclerosis Care: A Study of Canadian Neurologists. Frontiers in Neurology. 9. 781–781. 15 indexed citations
12.
Saposnik, Gustavo, Ángel Pérez Sempere, Daniel Prefasi, et al.. (2017). Decision-making in Multiple Sclerosis: The Role of Aversion to Ambiguity for Therapeutic Inertia among Neurologists (DIScUTIR MS). Frontiers in Neurology. 8. 65–65. 46 indexed citations
13.
14.
Lapierre, Yves, et al.. (2014). Switching from Injectable Therapy Leads to High Continuation Rate on Fingolimod (P7.221). Neurology. 82(10_supplement). 1 indexed citations
15.
Bhan, Virender, Yves Lapierre, Mark S. Freedman, et al.. (2014). Anti-JC Virus Antibody Prevalence in Canadian MS Patients. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 41(6). 748–752. 16 indexed citations
16.
Grand’Maison, François, Virender Bhan, Mark S. Freedman, et al.. (2013). Utility of the Canadian Treatment Optimization Recommendations (TOR) in MS Care. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 40(4). 527–535. 6 indexed citations
17.
Karampampa, Korinna, et al.. (2012). Treatment experience, burden, and unmet needs (TRIBUNE) in multiple sclerosis: the costs and utilities of MS patients in Canada.. PubMed. 19(1). e11–25. 61 indexed citations
18.
Saposnik, Gustavo, Sylvain Lanthier, Muhammad Mamdani, et al.. (2012). Fabry's Disease: A Prospective Multicenter Cohort Study in Young Adults with Cryptogenic Stroke. International Journal of Stroke. 7(3). 265–273. 6 indexed citations
19.
Montanera, Walter, et al.. (2010). Blunt Cerebrovascular Injuries: Diagnosis and Management Outcomes. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 37(5). 574–579. 31 indexed citations
20.
Freedman, Mark S., et al.. (2004). Treatment Optimization in Multiple Sclerosis. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 31(2). 157–168. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christian A. Bowers Breakdown of academic impact, for papers by Thomas Schenk Breakdown of academic impact, for papers by Virender Bhan Breakdown of academic impact, for papers by Shearwood McClelland Breakdown of academic impact, for papers by J. Gareth Noble Breakdown of academic impact, for papers by Kathleen Costello Breakdown of academic impact, for papers by Nhial T. Tutlam Breakdown of academic impact, for papers by Bruno P. Soares Breakdown of academic impact, for papers by Joel C. Morgenlander Breakdown of academic impact, for papers by John Y. Choi
Rankless by CCL
2026